Back to Results
First PageMeta Content
Biology / Chemistry / Darbepoetin alfa / Amgen / Erythropoietin / Royalties / Nuvelo / Eptifibatide / GlaxoSmithKline / Erythropoiesis-stimulating agents / Growth factors / Medicine


Reprint from January 8, 2007 BioCentury THE BERNSTEIN REPORT ARTICLE REPRINT
Add to Reading List

Document Date: 2008-03-07 11:41:50

Open Document

File Size: 37,73 KB

Share Result on Facebook

City

South San Francisco / San Francisco / Sunnyvale / Kenilworth / London / /

Company

Amgen Inc. / Nuvelo Inc. / Cytokinetics Inc. / Schering-Plough Corp. / BIOCENTURY PUBLICATIONS INC. / Cor Therapeutics Inc. / GlaxoSmithKline plc / D. / CYTK / /

Continent

North America / /

Country

United Kingdom / /

Currency

USD / /

Event

FDA Phase / /

/

MedicalCondition

Cancer / acute coronary syndromes / chronic heart failure / kidney disease / diabetes / heart failure / anemia / /

Person

Robert Blum / KAREN BERNSTEIN / Anne McNickle / Aaron Bouchie / /

/

Position

President / Chairman & Editor-in-Chief / spokesperson / director of business development and marketing / President / CEO / Ph. Chairman & Editor-in-Chief / /

Product

Integrilin / Aranesp / CK-1827452 / /

ProvinceOrState

New Jersey / California / /

URL

www.biocentury.com / /

SocialTag